TrialCancer medicine2020

Every-other-day palonosetron plus aprepitant for prevention of emesis following induction chemotherapy for acute myeloid leukemia: A randomized, controlled study from the "Rete Ematologica Pugliese".

Nicola Di Renzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.